Association Between Self-Reported Medication Adherence and Therapeutic Inertia in Hypertension: A Secondary Analysis of SPRINT (Systolic Blood Pressure Intervention Trial)

Therapeutic inertia (TI), failure to intensify antihypertensive medication when blood pressure (BP) is above goal, remains prevalent in hypertension management. The degree to which self-reported antihypertensive adherence is associated with TI with intensive BP goals remains unclear. Cross-sectional...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American Heart Association 2024-02, Vol.13 (3), p.e031574-e031574
Hauptverfasser:	Jacobs, Joshua A, Derington, Catherine G, Zheutlin, Alexander R, King, Jordan B, Cohen, Jordana B, Bucheit, John, Kronish, Ian M, Addo, Daniel K, Morisky, Donald E, Greene, Tom H, Bress, Adam P
Format:	Artikel
Sprache:	eng
Schlagworte:	adherence Adult Aged Antihypertensive Agents - pharmacology Antihypertensive Agents - therapeutic use Blood Pressure clinical practice pattern compliance Cross-Sectional Studies Female Humans hypertension Hypertension - drug therapy Hypertension - epidemiology Male Medication Adherence Original Research Self Report
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Therapeutic inertia (TI), failure to intensify antihypertensive medication when blood pressure (BP) is above goal, remains prevalent in hypertension management. The degree to which self-reported antihypertensive adherence is associated with TI with intensive BP goals remains unclear. Cross-sectional analysis was performed of the 12-month visit of participants in the intensive arm of SPRINT (Systolic Blood Pressure Intervention Trial), which randomized adults to intensive (
ISSN:	2047-9980 2047-9980
DOI:	10.1161/JAHA.123.031574